United States

People: Mesoblast Ltd (MSB.AX)

MSB.AX on Australia Stock Exchange

18 Aug 2017
Change (% chg)

$-0.05 (-2.70%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

O'Dwyer, Donal 

Mr. Donal P. O'Dwyer is an Non-Executive Independent Director of Mesoblast Ltd. He has over 25 years of experience as a senior executive in the global cardiovascular and medical devices industries. From 1996 to 2003, Mr O’Dwyer worked for Cordis Cardiology, the cardiology division of Johnson & Johnson’s Cordis Corporation, initially as its president (Europe) and from 2000 as its worldwide president. Prior to joining Cordis, he worked for 12 years with Baxter Healthcare, rising from plant manager in Ireland to president of the Cardiovascular Group, Europe, now Edwards Lifesciences. He is a qualified civil engineer, has a MBA and is on the Board of Directors of a number of life sciences companies including Cochlear Limited, Atcor Medical Holdings Ltd and Fisher & Paykel Healthcare Ltd.

Basic Compensation

Total Annual Compensation, AUD 160,750
Restricted Stock Awards, AUD --
Long-Term Incentive Plans, AUD --
All Other, AUD 15,271
Fiscal Year Total, AUD 176,021

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --